Last reviewed · How we verify
NCT05845073: PANDA
The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms
NA trial testing Probiotic in Antibiotic-associated Diarrhea in 69 participants. Completed in 25 July 2024.
25 July 2024
Quick facts
| Lead sponsor | The Archer-Daniels-Midland Company |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 69 |
| Start date | 9 May 2023 |
| Primary completion | 25 July 2024 |
| Estimated completion | 25 July 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Probiotic
- Placebo
Conditions studied
- Antibiotic-associated Diarrhea — all drugs for Antibiotic-associated Diarrhea →
Sponsor
The Archer-Daniels-Midland Company
Who can join
Adults 18 to 65, any sex, with Antibiotic-associated Diarrhea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effect of a multistrain probiotic on gastrointestinal (GI) complaints and diarrhoea in subjects receiving short-term antibiotic (AB) treatment
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05845073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Probiotic
Trials testing the same drug.
- NCT07529457 — Akk09 in Adults With Constipation · NA · not yet recruiting
- NCT07507955 — Probiotics for Constipation Relief in Adults · NA · not yet recruiting
- NCT07462481 — Probiotic Improve Constipation · NA · recruiting
- NCT07511855 — Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term T · Phase 2 · not yet recruiting
- NCT07474064 — Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC · Phase 2 · not yet recruiting
Other recruiting trials for Antibiotic-associated Diarrhea
Currently open trials in the same condition.
- NCT03895593 — Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections · recruiting
Other The Archer-Daniels-Midland Company trials
Trials by the same sponsor.
- NCT06710392 — Efficacy of Two Enzyme Cocktails in Healthy Adults · NA · not yet recruiting
- NCT06701604 — Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding · NA · not yet recruiting
- NCT05562739 — Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety · NA · completed
- NCT06103994 — Study to Assess the Effect of Multistrain Probiotic on the Immune Response to the Influenza Vaccination · NA · completed
- NCT06047145 — Evaluation of Soy Isoflavones on Skin Ageing Parameters · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05845073 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Archer-Daniels-Midland Company
- Last refreshed: 9 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05845073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing